Establishing molecular signatures of stroke focusing on omic approaches: a narrative review

References

• Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245–255.
   PubMed Web of Science ®Google Scholar
• Thrift AG, Thayabaranathan T, Howard G, et al. Global stroke statistics. Int J Stroke. 2017;12(1):13–32.
   PubMed Web of Science ®Google Scholar
• Gao X, Yang H, ZhiPing T. Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neurosci Lett. 2006;398(3):172–177.
   PubMed Web of Science ®Google Scholar
• Sakakibara BM, Kim AJ, Eng JJ. A systematic review and meta-analysis on self-management for improving risk factor control in stroke patients. Int J Behav Med. 2017;24(1):42–53.
   PubMed Web of Science ®Google Scholar
• Markus HS. Stroke genetics. Human Mol Genet. 2011;20(R2):R124–R131.
   PubMedGoogle Scholar
• Black M, Wang W, Wang W. Ischemic stroke: from next generation sequencing and GWAS to community genomics? Omics. 2015;19(8):451–460.
   PubMed Web of Science ®Google Scholar
• Munshi A, Rajeshwar K, Kaul S, et al. VNTR polymorphism in intron 4 of the eNOS gene and the risk of ischemic stroke in a South Indian population. Brain Res Bull. 2010;82(5-6):247–250.
   PubMed Web of Science ®Google Scholar
• Munshi A, Sharma V, Kaul S, et al. Estrogen receptor α genetic variants and the risk of stroke in a South Indian population from Andhra Pradesh. Clin Chim Acta. 2010;411(21-22):1817–1821.
   PubMed Web of Science ®Google Scholar
• Zee RY, Cheng S, Hegener HH, et al. Genetic variants of arachidonate 5-lipoxygenase–activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke. 2006;37(8):2007–2011.
   PubMed Web of Science ®Google Scholar
• Bevan S, Dichgans M, Gschwendtner A, et al. Variation in the PDE4D gene and ischemic stroke risk: a systematic review and meta-analysis on 5200 cases and 6600 controls. Stroke. 2008;39(7):1966–1971.
   PubMed Web of Science ®Google Scholar
• Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci. 2009;106(23):9362–9367.
   PubMed Web of Science ®Google Scholar
• Traylor M, Farrall M, Holliday EG, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11(11):951–962.
   PubMed Web of Science ®Google Scholar
• Malik R, MEGASTROKE Consortium, Chauhan G, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524–537.
   PubMed Web of Science ®Google Scholar
• Bellenguez C, The International Stroke Genetics Consortium (ISGC), Bevan S, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012;44(3):328–333.
   PubMed Web of Science ®Google Scholar
• Matarín M, Brown WM, Scholz S, et al. A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol. 2007;6(5):414–420.
   PubMed Web of Science ®Google Scholar
• Hata J, Matsuda K, Ninomiya T, et al. Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Human Mol Genet. 2007;16(6):630–639.
   PubMed Web of Science ®Google Scholar
• Gretarsdottir S, Thorleifsson G, Manolescu A, et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol. 2008;64(4):402–409.
   PubMed Web of Science ®Google Scholar
• Matsushita T, Ashikawa K, Yonemoto K, et al. Functional SNP of ARHGEF10 confers risk of atherothrombotic stroke. Human Mol Genet. 2010;19(6):1137–1146.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Fuku N, Tanaka M, et al. Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis. 2009;207(1):144–149.
   PubMed Web of Science ®Google Scholar
• Biffi A, on behalf of the International Stroke Genetics Consortium, Sonni A, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010;68(6):934–943.
   PubMed Web of Science ®Google Scholar
• Network NS, Pulit SL, McArdle PF, et al. The NINDS Stroke Genetics Network: a genome-wide association study of ischemic stroke and its subtypes. Lancet Neurol. 2016;15(2):174.
   PubMedGoogle Scholar
• Curtin SJ, Tiffin P, Guhlin J, et al. Validating genome-wide association candidates through quantitative variation in nodulation. Plant Physiol. 2017;173:01923.
   Web of Science ®Google Scholar
• Lanktree MB, Dichgans M, Hegele RA. Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke. 2010;41(4):825–832.
   PubMed Web of Science ®Google Scholar
• Bevan S, Markus HS. Genetics of common polygenic ischaemic stroke: current understanding and future challenges. Stroke Res Treat. 2011;2011:1–6.
   Google Scholar
• Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet. 2010;11(6):415–425.
   PubMed Web of Science ®Google Scholar
• Manry J, Quintana-Murci L. A genome-wide perspective of human diversity and its implications in infectious disease. Cold Spring Harbor Pers Med. 2013;3(1):a012450–a012450.
   PubMed Web of Science ®Google Scholar
• Polychronopoulos P, Gioldasis G, Ellul J, et al. Family history of stroke in stroke types and subtypes. J Neurol Sci. 2002;195(2):117–122.
   PubMed Web of Science ®Google Scholar
• Jerrard-Dunne P, Cloud G, Hassan A, et al. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke. 2003;34(6):1364–1369.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Sakuma J, Takeuchi I, et al. Identification of six polymorphisms as novel susceptibility loci for ischemic or hemorrhagic stroke by exome-wide association studies. Int J Mol Med. 2017;39(6):1477–1491.
   PubMed Web of Science ®Google Scholar
• Oguri M, Kato K, Fujimaki T, et al. Identification of six polymorphisms as novel susceptibility loci for ischemic or hemorrhagic stroke by exome-wide association studies. Int J Mol Med. 2017;39(6):1477–1491.
   PubMed Web of Science ®Google Scholar
• Cole JW, Stine OC, Liu X, et al. Rare variants in ischemic stroke: an exome pilot study. PLoS One. 2012;7(4):e35591.
   PubMed Web of Science ®Google Scholar
• Kim DS, Crosslin DR, Auer PL, et al. Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project. J Lipid Res. 2014;55(6):1173–1178.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tong Y, Zhang Y, et al. Two novel susceptibility SNPs for ischemic stroke using exome sequencing in Chinese Han population. Mol Neurobiol. 2014;49(2):852–862.
   PubMed Web of Science ®Google Scholar
• Auer PL, Nalls M, Meschia JF, et al. Rare and coding region genetic variants associated with risk of ischemic stroke: the NHLBI Exome Sequence Project. JAMA Neurol. 2015;72(7):781–788.
   PubMed Web of Science ®Google Scholar
• Söderholm M, Almgren P, Jood K, et al. Exome array analysis of ischaemic stroke: results from a southern Swedish study. Eur J Neurol. 2016;23(12):1722–1728.
   PubMed Web of Science ®Google Scholar
• Malik R, International Stroke Genetics Consortium, Dau T, et al. Common coding variant in SERPINA1 increases the risk for large artery stroke. Proc Natl Acad Sci USA. 2017;114(14):3613–3618.
   PubMed Web of Science ®Google Scholar
• Flanagan JM, Sheehan V, Linder H, et al. Genetic mapping and exome sequencing identify two mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood, American Society of Hematology 2013;121(16):3237–3245.
   Google Scholar
• Vasudeva K, Chaurasia P, Singh S, et al. Genetic signatures in ischemic stroke: focus on aspirin resistance. CNS Neurol Disord-Drug Targ. 2017;16(9):974–982.
   PubMed Web of Science ®Google Scholar
• Musunuru K, Ingelsson E, Fornage M, et al. The expressed genome in cardiovascular diseases and stroke: refinement, diagnosis, and prediction: a scientific statement from the American Heart Association. Circ: Genomic Precis Med. 2017;10(4):e000037.
   Google Scholar
• Sharp FR, Jickling GC, Stamova B, et al. Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. J Cereb Blood Flow Metab. 2011;31(7):1513–1531.
   PubMed Web of Science ®Google Scholar
• Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics. 2004;113(2):394–396.
   PubMed Web of Science ®Google Scholar
• Choi JK, Kim SC. Environmental effects on gene expression phenotype have regional biases in the human genome. Genetics. 2007;175(4):1607–1613.
   PubMed Web of Science ®Google Scholar
• Richards AL, Watza D, Findley A, Alazizi A, et al. Environmental perturbations lead to extensive directional shifts in RNA processing. PLoS Genet. 2017;13(10):e1006995.
   PubMed Web of Science ®Google Scholar
• White RJ, Sharrocks AD. Coordinated control of the gene expression machinery. Trends Genet. 2010;26(5):214–220.
   PubMed Web of Science ®Google Scholar
• Tang Y, Lu A, Aronow BJ, et al. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol. 2001;50(6):699–707.
   PubMed Web of Science ®Google Scholar
• Tang Y, Lu A, Aronow BJ, et al. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci. 2002;15(12):1937–1952.
   PubMed Web of Science ®Google Scholar
• Tang Y, Nee AC, Lu A, et al. Blood genomic expression profile for neuronal injury. J Cereb Blood Flow Metab. 2003;23(3):310–319.
   PubMed Web of Science ®Google Scholar
• Lu XC, Williams AJ, Yao C, et al. Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res. 2004;77(6):843–857.
   PubMed Web of Science ®Google Scholar
• Moore DF, Li H, Jeffries N, et al. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation. 2005;111(2):212–221.
   PubMed Web of Science ®Google Scholar
• Tang Y, Gilbert DL, Glauser TA, et al. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol. 2005;62(2):210–215.
   PubMedGoogle Scholar
• Vemuganti R, Dempsey RJ. Carotid atherosclerotic plaques from symptomatic stroke patients share the molecular fingerprints to develop in a neoplastic fashion: a microarray analysis study. Neuroscience. 2005;131(2):359–374.
   PubMed Web of Science ®Google Scholar
• Tang Y, Xu H, Du XL, et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab. 2006;26(8):1089–1102.
   PubMed Web of Science ®Google Scholar
• Stamova B, Xu H, Jickling G, et al. Gene expression profiling of blood for the prediction of ischemic stroke. Stroke. 2010;41(10):2171–2177.
   PubMed Web of Science ®Google Scholar
• Du X, Tang Y, Xu H, et al. Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics. 2006;87(6):693–703.
   PubMed Web of Science ®Google Scholar
• Grond-Ginsbach C, Hummel M, Wiest T, et al. Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke. J Neurol. 2008;255(5):723–731.
   PubMed Web of Science ®Google Scholar
• Tischkau SA, Cohen JA, Stark JT, et al. Time-of-day affects expression of hippocampal markers for ischemic damage induced by global ischemia. Exp Neurol. 2007; 208(2):314–322.
   PubMed Web of Science ®Google Scholar
• Xu H, Tang Y, Liu DZ, et al. Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. J Cereb Blood Flow Metab. 2008;28(7):1320–1328.
   PubMed Web of Science ®Google Scholar
• Jickling GC, Xu H, Stamova B, et al. Signatures of cardioembolic and large‐vessel ischemic stroke. Ann Neurol. 2010;68(5):681–692.
   PubMed Web of Science ®Google Scholar
• Jickling GC, Stamova B, Ander BP, et al. Profiles of lacunar and nonlacunar stroke. Ann Neurol. 2011;70(3):477–485.
   PubMed Web of Science ®Google Scholar
• Stamova B, Jickling GC, Ander BP, et al. Gene expression in peripheral immune cells following cardioembolic stroke is sexually dimorphic. PLoS One. 2014;9(7):e102550.
   PubMed Web of Science ®Google Scholar
• Jickling GC, Stamova B, Ander BP, et al. Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location. Stroke. 2012;43(8):2036–2041.
   PubMed Web of Science ®Google Scholar
• Barr TL, Conley Y, Ding J, et al. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology. 2010;75(11):1009–1014.
   PubMed Web of Science ®Google Scholar
• Montaner J, Alvarez-Sabín J, Molina C, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke. 2001;32(8):1759–1766.
   PubMed Web of Science ®Google Scholar
• Horstmann S, Kalb P, Koziol J, et al. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke. 2003;34(9):2165–2170.
   PubMed Web of Science ®Google Scholar
• Graves PR, Haystead TA. Molecular biologist’s guide to proteomics. Microbiol Mol Biol Rev. 2002;66(1):39–63.
   PubMed Web of Science ®Google Scholar
• Aslam B, Basit M, Nisar MA, et al. Proteomics: technologies and their applications. J Chromatogr Sci. 2017;55(2):182–196.
   PubMed Web of Science ®Google Scholar
• Santana NR, Muñiz EZ, Cocho D, et al. Analysis of peptidome profiling of serum from patients with early onset symptoms of ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(2):235–240.
   PubMed Web of Science ®Google Scholar
• Crowley, M G, Grant Liska M, Lippert T, et al. Utilizing delta opioid receptors and peptides for cytoprotection: implications in stroke and other neurological disorders. CNS Neurol Disord-Drug Targ. 2017;16(4):414–424.
   PubMed Web of Science ®Google Scholar
• Fassbender K, Schmidt R, Schreiner A, et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci. 1997;148(1):101–105.
   PubMed Web of Science ®Google Scholar
• Allard L, Burkhard PR, Lescuyer P, et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem. 2005;51(11):2043–2051.
   PubMed Web of Science ®Google Scholar
• Tamam Y, Iltumur K, Apak I. Assessment of acute phase proteins in acute ischemic stroke. Tohoku J Exp Med. 2005;206(2):91–98.
   PubMed Web of Science ®Google Scholar
• Barber M, Morton JJ, Macfarlane PW, et al. Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis. 2007;23(4):260–266.
   PubMed Web of Science ®Google Scholar
• Cuadrado E, Rosell A, Colomé N, et al. The proteome of human brain after ischemic stroke. J Neuropathol Exp Neurol. 2010;69(11):1105–1115.
   PubMed Web of Science ®Google Scholar
• Bergerat A, Decano J, Wu CJ, et al. Prestroke proteomic changes in cerebral microvessels in stroke-prone, transgenic [hCETP]-Hyperlipidemic, Dahl salt-sensitive hypertensive rats. Mol Med. 2011;17(7-8):588–598.
   PubMed Web of Science ®Google Scholar
• Datta A, Akatsu H, Heese K, et al. Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology. J Proteomics. 2013;91:556–568.
   PubMed Web of Science ®Google Scholar
• Lind L, Siegbahn A, Lindahl B, et al. Discovery of new risk markers for ischemic stroke using a novel targeted proteomics chip. Stroke. 2015;46(12):3340–3347.
   PubMed Web of Science ®Google Scholar
• Walsh KB, Hart K, Roll S, et al. Apolipoprotein AI and paraoxonase-1 are potential blood biomarkers for ischemic stroke diagnosis. J Stroke Cerebrovasc Dis. 2016;25(6):1360–1365.
   PubMed Web of Science ®Google Scholar
• Cevik O, Baykal AT, Sener A. Platelets proteomic profiles of acute ischemic stroke patients. PLoS One. 2016;11(6):e0158287.
   PubMed Web of Science ®Google Scholar
• Nguyen VA, Carey LM, Giummarra L, et al. A pathway proteomic profile of ischemic stroke survivors reveals innate immune dysfunction in association with mild symptoms of depression–a pilot study. Front Neurol. 2016;7:85.
   PubMed Web of Science ®Google Scholar
• Muñoz R, Santamaría E, Rubio I, et al. Mass spectrometry-based proteomic profiling of thrombotic material obtained by endovascular thrombectomy in patients with ischemic stroke. IJMS. 2018;19(2):498.
   Google Scholar
• Penn AM, on behalf of the SpecTRA study group, Bibok MB, et al. Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: phase 1 of SpecTRA, a large scale translational study. Biomarkers. 2018;23(4):392–405.
   PubMed Web of Science ®Google Scholar
• Lee Y, Khan A, Hong S, et al. A metabolomic study on high-risk stroke patients determines low levels of serum lysine metabolites: a retrospective cohort study. Mol BioSyst. 2017;13(6):1109–1120.
   PubMedGoogle Scholar
• Holmes MV, Millwood IY, Kartsonaki C, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol. 2018;71(6):620–632.
   PubMed Web of Science ®Google Scholar
• Jung JY, Lee HS, Kang DG, et al. 1H-NMR-based metabolomics study of cerebral infarction. Stroke. 2011;42(5):1282–1288.
   PubMed Web of Science ®Google Scholar
• Jove M, Mauri-Capdevila G, Suarez I, et al. Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology. 2015;84(1):36–45.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang XA. A novel urinary metabolite signature for non-invasive post-stroke depression diagnosis. Cell Biochem Biophys. 2015;72(3):661–667.
   PubMed Web of Science ®Google Scholar
• Deng W, Beecher C, Burant C, et al. Metabolomic analysis reveals novel small molecules plasma markers of hyperacute ischemic stroke (S30.001). Neurology. 2015;84(14):S30.001.
   Google Scholar
• Yu B, Gottesman RF, Mosley TH, et al. Abstract TMP60: a prospective study of serum metabolites and risk of ischemic stroke. Stroke. 2017;48(suppl_1):ATMP60.
   Google Scholar
• Wang Y, Wang Y-G, Ma T-F, et al. Dynamic metabolites profile of cerebral ischemia/reperfusion revealed by 1H NMR-based metabolomics contributes to potential biomarkers. Int J Clin Exp Path. 2014;7(7):4067–4075.
   PubMed Web of Science ®Google Scholar
• Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res. 2007;313(10):2050–2062.
   PubMed Web of Science ®Google Scholar
• Tang JD, Lampe KJ. From de novo peptides to native proteins: advancements in biomaterial scaffolds for acute ischemic stroke repair. Biomed Mater. 2018;13(3):034103.
   PubMed Web of Science ®Google Scholar
• Yulug B, Hanoglu L, Kilic E. Commentary: toward a personalized medicine in wake-up stroke? CNS Neurol Disord-Drug Targ. 2017;16(10):1049.
   PubMed Web of Science ®Google Scholar